Australia's Emyria rises to 5-month high after global services platform launch
20/04/2026 05:23
** Shares of Emyria EMD.AX rise as much as 45.8% to A$0.07, their highest level since November 12, 2025 ** Set for its best session since September 4, 2023, if gains hold ** The early-stage drug developer launches a global services platform enabling international drug sponsors to access company's clinical delivery infrastructure ** About 45 million shares change hands, 40 times the 30-day avg (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))